Cabinet Approves National Medical Devices Policy
The Union Cabinet approved the National Medical Devices Policy, 2023, in its meeting on Wednesday.
The market size of the medical devices sector in India is estimated to be $11 billion, or approximately Rs 90,000 crore, as of 2020 and its share in the global medical device market is estimated to be 1.5%, according to a press release.
"(The) sector is on a growth track and has an enormous potential to become self-reliant and to contribute towards the goal of universal healthcare," it said.
The government has already initiated implementation of the production-linked incentive scheme for medical devices and support for setting up of four medical devices parks in Himachal Pradesh, Madhya Pradesh, Tamil Nadu and Uttar Pradesh.
Under the PLI scheme for medical devices, 26 projects have been approved with a committed investment of Rs 1,206 crore and an investment of Rs 714 crore has been achieved so far.
Out of these:
Fourteen projects producing 37 products have been commissioned and domestic manufacturing of high-end medical devices has started. It includes linear accelerator, MRI scan, CT-scan, mammogram, C-Arm, MRI coils, high end X-ray tubes.
Remaining 12 products will be commissioned in the near future.
Five projects out of total 26 projects have been approved recently under Category B for domestic manufacturing of 87 products or product components.
"Building upon these measures, a holistic policy framework to accelerate this growth and fulfil the potential of the sector is the need of the hour," it said.
The National Medical Devices Policy, 2023, is expected to facilitate an orderly growth of the medical device sector to meet the public health objectives of access, affordability, quality and innovation.
Encouraging domestic investments and production of medical devices complements the Union government's self-reliant India and 'Make in India' programmes.
The policy is expected to propel the sector to cater to healthcare needs of not only India, but also the world, it said.
Vision And Mission
Emerge as global leader in the manufacturing and innovation of medical devices by achieving 10–12% share globally over the next 25 years.
The policy is expected to help the sector grow from $11 billion at present to $50 billion by 2030.
Lay a roadmap for accelerated growth of the medical devices sector to achieve access and universality, affordability, quality, patient-centred and quality care, preventive and promotive health, security, research and innovation, and skilled manpower.
Strategies To Promote Sector
Single window clearance system for licensing of medical devices, enhancing the role of Indian standards like the Bureau of Indian Standards and designing coherent pricing regulation will be followed.
Establishment of large medical device parks, clusters with world-class common infrastructure facilities in proximity to economic zones with requisite logistics connectivity.
Promote research and development innovation, establish centres of excellence and support startups.
Attract private investments in the sector.
Measures to have a steady supply of skilled workforce.
Creation of a dedicated export promotion council for the sector under the department. It will be an enabler to deal with various market access issues.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.